Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Multicenter, Randomized, Open-label Clinical Trial Comparing Treatment with Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control with Hyaluronic Acid in Patients with Knee Osteoarthritis

NCT05086939 is registered in ClinicalTrials.gov with Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León as lead sponsor.

NCT NCT05086939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05086939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Multicenter, Randomized, Open-label Clinical Trial Comparing Treatment with Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control with Hyaluronic Acid in Patients with Knee Osteoarthritis
Lead sponsor
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Phase
Phase 3
Overall status
Active, not recruiting
Start date
May 26, 2021
Completion date
May 31, 2026
Enrollment
124 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis